Profil
Mr. Jonathan Half is a Managing Director & Co-Portfolio Manager at Ion Asset Management (Israel) Ltd. He is on the Board of Directors at Ion Asset Management (Israel) Ltd.
Prior to founding ION Asset Management, Mr. Half spent 13 years in equity research at numerous institutions, including UBS, First Manhattan, Lehman Brothers and Oscar Gruss.
Jonathan opened the UBS Israel office in 1998 and covered Israeli equities during his 7 years.
He holds a BSc in Industrial Engineering and Management from Tel Aviv University and an MBA (Hons) from Columbia University.
Aktive Positionen von Jonathan Half
| Unternehmen | Position | Beginn |
|---|---|---|
Ion Asset Management (Israel) Ltd.
Ion Asset Management (Israel) Ltd. Investment ManagersFinance ION combines a bottom-up approach and proprietary fundamental research to deliver unique insight and value for their clients. The firm focuses investment on Israeli and Israeli-related companies with global exposure. | Portfolio Manager-Fixed Income | 01.01.2006 |
Ion Asset Management Ltd.
Ion Asset Management Ltd. Investment ManagersFinance Provides financial services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jonathan Half
| Unternehmen | Position | Ende |
|---|---|---|
UBS Securities Israel Ltd.
UBS Securities Israel Ltd. Investment Banks/BrokersFinance Specializes in brokerage services | Analyst-Equity | 03.04.2006 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
UBS Securities Israel Ltd.
UBS Securities Israel Ltd. Investment Banks/BrokersFinance Specializes in brokerage services | Finance |
Ion Asset Management Ltd.
Ion Asset Management Ltd. Investment ManagersFinance Provides financial services | Finance |
Ion Asset Management (Israel) Ltd.
Ion Asset Management (Israel) Ltd. Investment ManagersFinance ION combines a bottom-up approach and proprietary fundamental research to deliver unique insight and value for their clients. The firm focuses investment on Israeli and Israeli-related companies with global exposure. | Finance |
















